Windtree Therapeutics' AEROSURF Drug Delivery Device Secures US Patent

United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,874,818 to Windtree Therapeutics Inc (NASDAQ: WINT), covering features of the aerosol delivery system for AEROSURF drug delivery device.
The new aerosol delivery system also implements design changes to potentially mitigate the risks of device-related treatment interruptions experienced in the prototype device used in the AEROSURF Phase 2b trial.
This patent protection covers device elements that will facilitate modification for use in a broader range of patients, including adults with respiratory disease or drug delivery.
Additionally, the patent allows for the aerosol delivery system to include a power control unit and operation interface. The patent extends the Company's device protection until 2039.
Price Action: WINT increased 0.73% at $5.54 during market hours on the last check Tuesday.